ID   CUTO-37-CR
AC   CVCL_C8T7
SY   CUTO37CR
DR   Wikidata; Q123030999
RX   DOI=10.1158/1535-7163.TARG-21-P076;
CC   Selected for resistance to: ChEBI; CHEBI_64310; Crizotinib (Xalkori).
CC   Sequence variation: Gene fusion; HGNC; HGNC:1697; CD74 + HGNC; HGNC:10261; ROS1; Name(s)=CD74-ROS1 (DOI=10.1158/1535-7163.TARG-21-P076).
CC   Omics: Transcriptome analysis by RNAseq.
DI   NCIt; C3512; Lung adenocarcinoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
HI   CVCL_C8T3 ! CUTO-37
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 19-12-24; Version: 3
//
RX   DOI=10.1158/1535-7163.TARG-21-P076;
RA   Tyler L.C., Le A.T., Nijmeh H., Bao L.-M., Turner K.,
RA   Christianson J., Doebele R.C.;
RT   "Novel mechanisms of acquired TKI resistance in ROS1+ NSCLC.";
RL   Mol. Cancer Ther. 20 Suppl. 12:P076-P076(2021).
//